• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Controlled trial of amantadine hydrochloride in Parkinson's disease.

作者信息

Jorgensen P B, Bergin J D, Haas L, Cuningham J A, Morah D D, Pollock M, Robinson R G, Spears G F

出版信息

N Z Med J. 1971 May;73(468):263-7.

PMID:4932146
Abstract
摘要

相似文献

1
Controlled trial of amantadine hydrochloride in Parkinson's disease.
N Z Med J. 1971 May;73(468):263-7.
2
Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
Trans Am Neurol Assoc. 1971;96:307-8.
3
[Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Wien Med Wochenschr. 1971 May 8;121(19):390-7.
4
[Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
HNO. 1970 Nov;18(11):390-7.
5
[Amantadine hydrochloride in the treatment of Parkinson's syndrome].
Rev Esp Otoneurooftalmol Neurocir. 1971 Jan-Feb;29(167):45-9.
6
L-dopa and amantadine hydrochloride in Parkinson's disease.
Int Z Klin Pharmakol Ther Toxikol. 1971 Apr;4(3):356-60.
7
Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
Med J Aust. 1970 Oct 3;2(14):626-9.
8
Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Trans Am Neurol Assoc. 1969;94:85-90.
9
A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
Curr Ther Res Clin Exp. 1973 Aug;15(8):552-8.
10
[Amantadine treatment in Parkinson's disease].[金刚烷胺治疗帕金森病]
Nord Med. 1970 Nov 26;84(48):1518-20.

引用本文的文献

1
The New Zealand Parkinson's progression programme.新西兰帕金森病进展项目。
J R Soc N Z. 2022 Aug 14;53(4):466-488. doi: 10.1080/03036758.2022.2111448. eCollection 2023.
2
Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?用于中枢神经系统疾病和损伤临床试验的抗炎和神经保护药物：我们将何去何从？
Front Immunol. 2020 Sep 10;11:2021. doi: 10.3389/fimmu.2020.02021. eCollection 2020.
3
Amantadine in Parkinson's disease.金刚烷胺在帕金森病中的应用。
Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.
4
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.左旋多巴：对其药理特性及治疗用途的综述，特别提及帕金森病
Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002.